A single-shot COVID-19 vaccine made by Johnson & Johnson completely prevented hospitalizations and deaths in…
View More FDA review reveals J&J COVID-19 vaccine safe, effective
FDA Approves Breyanzi
FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large…
View More FDA Approves Breyanzi
FDA Approves Cabenuva and Vocabria
FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV…
View More FDA Approves Cabenuva and Vocabria
FDA issues warning about metal in face masks after patient burned during MRI
Britain starts first coronavirus vaccines 70 hospitals in the U.K. have started administering Pfizer vaccine;…
View More FDA issues warning about metal in face masks after patient burned during MRI
FDA approves drug for PET imaging of prostate cancer
(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET)…
View More FDA approves drug for PET imaging of prostate cancer
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
HOUSTON, Dec. 1, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a…
View More Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
Beware of coronavirus scams as vaccine approaches FDA approval: officials
Moderna to apply for emergency coronavirus vaccine approval HHS Secretary Alex Azar calls recent vaccine…
View More Beware of coronavirus scams as vaccine approaches FDA approval: officials
FDA clears Eli Lilly COVID-19 antibody treatment for emergency use
Why Pfizer’s ‘ultra-cold’ COVID-19 vaccine presents logistical challenges Dr. Amesh Adalja discusses the risks and…
View More FDA clears Eli Lilly COVID-19 antibody treatment for emergency use
FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)
TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that…
View More FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that…
View More FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma